| Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) (NCT01374425) | Genentech, Inc. | 2011-08-01 |
| The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer (NCT01426490) | Taichung Veterans General Hospital | 2011-08-01 |
| Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF (NCT01367275) | M.D. Anderson Cancer Center | 2011-08-01 |
| Comparative Effectiveness of CTC & OC (NCT02143115) | Fox Chase Cancer Center | 2011-08-01 |
| Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making (NCT01558583) | University of North Carolina, Chapel Hill | 2011-07-01 |
| An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer (NCT01696695) | Hoffmann-La Roche | 2011-07-01 |
| Angiogenic Switch in Patients With Colorectal Cancer (NCT02075086) | Grupo Hospital de Madrid | 2011-07-01 |
| Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer (NCT01575340) | Universidade Federal de Santa Catarina | 2011-07-01 |
| 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer (NCT01417494) | Federation Francophone de Cancerologie Digestive | 2011-07-01 |
| Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders (NCT01438385) | Weill Medical College of Cornell University | 2011-07-01 |
| An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer (NCT01399190) | Hoffmann-La Roche | 2011-07-01 |
| Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study (NCT01464151) | UMC Utrecht | 2011-07-01 |
| Prehabilitation in Liver Surgery (NCT01523353) | Liverpool University Hospitals NHS Foundation Trust | 2011-07-01 |
| Multimodal Prehabilitation for Colorectal Surgery (NCT01356264) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2011-07-01 |
| Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors (NCT01364844) | Daiichi Sankyo | 2011-07-01 |
| Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer (NCT01397747) | Exact Sciences Corporation | 2011-06-01 |
| Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT (NCT01372527) | Massachusetts General Hospital | 2011-06-01 |
| Magnesium and Rotational Thromboelastometry (ROTEM) in Colorectal Cancer Surgery (NCT01938300) | Seoul National University Bundang Hospital | 2011-06-01 |
| A Randomized Control Trial of a Simulation-based Curriculum to Enhance Skills in Colonoscopy (NCT01991522) | Unity Health Toronto | 2011-06-01 |
| A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab (NCT01338558) | Hoffmann-La Roche | 2011-06-01 |
| A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients (NCT01300858) | EGEN, Inc. | 2011-06-01 |
| TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC) (NCT01362361) | Martin-Luther-Universität Halle-Wittenberg | 2011-06-01 |
| Early Rehabilitation of Cancer Patients (NCT01588262) | Haukeland University Hospital | 2011-05-01 |
| Specimens for Septin 9 Performance (NCT01329718) | Epigenomics, Inc | 2011-05-01 |
| Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT01390818) | EMD Serono | 2011-05-01 |
| Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT01375816) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2011-05-01 |
| Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4 (NCT01726309) | Cancer Trials Ireland | 2011-05-01 |
| Exercise and Metformin in Colorectal and Breast Cancer Survivors (NCT01340300) | Dana-Farber Cancer Institute | 2011-05-01 |
| Study of In-home Tests for Colorectal Cancer (NCT01998009) | Centers for Disease Control and Prevention | 2011-05-01 |
| Zinc Supplementation on Markers of Oxidative Stress in Post Operative Colorectal Cancer During Chemotherapy Cycles (NCT02106806) | University of Sao Paulo | 2011-05-01 |
| Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer (NCT02849106) | Institut Curie | 2011-05-01 |
| Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer (NCT01531777) | Jiangsu HengRui Medicine Co., Ltd. | 2011-04-01 |
| Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial (NCT01344304) | Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group | 2011-04-01 |
| Effect of Intravenous Lidocaine on the Tolerability of Early Oral Feeding After Laparoscopic Colorectal Surgery (NCT01346917) | Kangbuk Samsung Hospital | 2011-04-01 |
| Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer (NCT01309126) | HiberCell, Inc. | 2011-04-01 |
| A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer (NCT01326000) | Hoffmann-La Roche | 2011-04-01 |
| A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck (NCT01059643) | Eli Lilly and Company | 2011-04-01 |
| Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects (NCT01834742) | Norgine | 2011-04-01 |
| Precision-Based Magnesium Trial (NCT01105169) | Vanderbilt University Medical Center | 2011-03-11 |
| Ancillary Study of Methylation Biomarkers in a Randomized Controlled Trial of a Personalized Prevention of Colorectal Cancer (NCT04196803) | Vanderbilt University Medical Center | 2011-03-11 |
| Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) (NCT01327612) | Amgen | 2011-03-03 |
| Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors (NCT01311856) | M.D. Anderson Cancer Center | 2011-03-01 |
| BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer (NCT01791140) | Hoffmann-La Roche | 2011-03-01 |
| Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI (NCT01312467) | National Cancer Institute (NCI) | 2011-03-01 |
| Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety (NCT01465451) | Sun Yat-sen University | 2011-03-01 |
| Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy (NCT01378143) | Oncozyme Pharma Inc. | 2011-03-01 |
| Epidural Versus Patient-controlled Analgesia for Reduction in Long-term Mortality Following Colorectal Cancer Surgery (NCT01318161) | Örebro University, Sweden | 2011-03-01 |
| Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer (NCT01322152) | Fudan University | 2011-03-01 |
| Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention (NCT01405638) | NYU Langone Health | 2011-03-01 |
| Colonoscopy Screening Using a Novel Slim Colonoscope - a Randomized Controlled Trial (NCT01370928) | Sorlandet Hospital HF | 2011-03-01 |
| An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer (NCT01319877) | Hoffmann-La Roche | 2011-03-01 |
| Time Schedules for Sending Invitations to Colonoscopy Screening (NCT01505972) | Maria Sklodowska-Curie National Research Institute of Oncology | 2011-03-01 |
| Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients (NCT01320319) | University of Nottingham | 2011-03-01 |
| Colorectal Cancer Awareness, Research, Education and Screening (CARES) (NCT01804179) | H. Lee Moffitt Cancer Center and Research Institute | 2011-02-11 |
| Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer (NCT01290926) | Jules Bordet Institute | 2011-02-01 |
| A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer (NCT01304602) | University of Kansas Medical Center | 2011-02-01 |
| Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor Cells (NCT01286883) | Milton S. Hershey Medical Center | 2011-02-01 |
| Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases (NCT01442935) | UNICANCER | 2011-02-01 |
| Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy (NCT01079780) | Eastern Cooperative Oncology Group | 2011-01-18 |
| Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay (NCT01214512) | Meir Medical Center | 2011-01-01 |
| High Dose Vitamin D Study (NCT01150877) | University of British Columbia | 2011-01-01 |
| Association Between Hepatitis C Infection and Renal Cell Carcinoma (NCT01405183) | Henry Ford Health System | 2011-01-01 |
| Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal Surgery (NCT01269060) | National Cancer Center, Korea | 2011-01-01 |
| Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab (NCT01276379) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2011-01-01 |
| Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer (NCT01284504) | Stanford University | 2011-01-01 |
| Effects of Weight on Inflammation and Colon Cancer Risk (NCT02884024) | Tufts University | 2011-01-01 |
| Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer (NCT01279681) | Alliance for Clinical Trials in Oncology | 2011-01-01 |
| Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser Endomicroscopy (NCT01372189) | Shandong University | 2011-01-01 |
| Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy (NCT01518023) | University of Sao Paulo | 2011-01-01 |
| Fast Track Laparoscopic Surgery: A Better Option for Treating Colorectal Cancer Than Conventional Laparoscopic Surgery (NCT01969591) | Quan Wang | 2011-01-01 |
| Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs: A Propensity Analysis (NCT04258098) | Third Affiliated Hospital, Sun Yat-Sen University | 2011-01-01 |
| Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure (NCT01348412) | Centre Georges Francois Leclerc | 2010-12-15 |
| A Randomised Trial of Pulmonary Metastasectomy in Colorectal Cancer (NCT01106261) | University College, London | 2010-12-02 |
| A Study in Second Line Metastatic Colorectal Cancer (NCT01183780) | Eli Lilly and Company | 2010-12-02 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only (NCT01226719) | SCRI Development Innovations, LLC | 2010-12-01 |
| Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients (NCT01322178) | Fudan University | 2010-12-01 |
| Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer (NCT01305980) | SBPharmaceutical IND, Co., LTD | 2010-12-01 |
| Korean CRC Screening Study PT13599 (NCT04478110) | Temple University | 2010-12-01 |
| Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer (NCT01251536) | Universitaire Ziekenhuizen KU Leuven | 2010-12-01 |
| Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab (NCT01442649) | UNICANCER | 2010-12-01 |
| Doctor-Recommended Home-Based Exercise Program or Relaxation Training in Improving Physical Function and Controlling Symptoms in Patients With Stage IV or Recurrent Colon Cancer That Cannot Be Removed By Surgery (NCT00985400) | M.D. Anderson Cancer Center | 2010-11-05 |
| Curcumin Biomarkers (NCT01333917) | University of North Carolina, Chapel Hill | 2010-11-01 |
| Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC (NCT01282658) | Huazhong University of Science and Technology | 2010-11-01 |
| Redes III Patient Navigator Qol Study (NCT02275754) | The University of Texas Health Science Center at San Antonio | 2010-11-01 |
| Fast-track Perioperative Program for Laparoscopic Colorectal Surgery (NCT01341366) | Chinese University of Hong Kong | 2010-11-01 |
| Colorectal Cancer Detection by Means of Optical Fluoroscopy (NCT01286064) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2010-10-01 |
| Increasing Colorectal Cancer Screening in a Safety-net Health System With a Focus on the Uninsured: Benefits and Costs (NCT01191411) | University of Texas Southwestern Medical Center | 2010-10-01 |
| Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI (NCT01885702) | Radboud University Medical Center | 2010-10-01 |
| Molecular Screening for Lynch Syndrome in Southern Denmark (NCT01216930) | Vejle Hospital | 2010-10-01 |
| Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. (NCT01229813) | Lund University Hospital | 2010-10-01 |
| Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies (NCT01260168) | Exact Sciences Corporation | 2010-10-01 |
| An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases (NCT01343901) | Hoffmann-La Roche | 2010-09-30 |
| An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer (NCT01266564) | Hoffmann-La Roche | 2010-09-03 |
| Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening? (NCT01279278) | University of Paris 5 - Rene Descartes | 2010-09-01 |
| Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients (NCT01215539) | Hellenic Cooperative Oncology Group | 2010-09-01 |
| Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort (NCT01904955) | Centre Hospitalier Universitaire Dijon | 2010-09-01 |
| Regional Native American Community Networks Program (RNACNP) (NCT02843217) | Washington State University | 2010-09-01 |
| Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV) (NCT01448655) | IFAG AG | 2010-09-01 |
| Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening? (NCT01279330) | University of Paris 5 - Rene Descartes | 2010-09-01 |